Nephroscan Injection, Powder, Lyophilized, For Solution
Product Images NDC 71083-0020

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nephroscan (NDC 71083-0020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Theragnostics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image (Nephroscan 01)

Image (Nephroscan 01)
This appears to be a chromatography data analysis report indicating the distance traveled by solute (a compound of Technetium Tc 99m) and solvent (n-butanol/3N HCI) during the experiment. It also mentions the ratios of free and hydrolyzed Tc 99m to the bound Tc 99m succimer compound.*
FDA Label Image

Image (Nephroscan 02)

Image (Nephroscan 02)
This text describes a formula to calculate the percent rachiochemical purity of Technetium Tc 99m succimer activity. The formula involves measuring the total activity of Te 99m succimer, HR Tc 99m, and Unbound Tc 99m, and multiplying it by 100 to get the percentage.*
FDA Label Image

Chemical Structure (Nephroscan 03)

Chemical Structure (Nephroscan 03)
FDA Label Image

Principal Display Panel (1 mg Vial Carton)

Principal Display Panel (1 mg Vial Carton)
Nephroscan is a kit for the preparation of Technetium Tc 99m Succimer Injection, which is used as a radiopharmaceutical. It comes in 5 single-use vials, each containing a specific amount of the drug ingredients. The drug must be stored in the original container at a temperature range of 2° to 8°C and must not be frozen. After radiolabeling, store the drug upright in appropriate shielding, at 20° to 25°C with excursions permitted, but it must not be used and discarded 4 hours after reconstitution. Only licensed health care professionals trained in the safe use of radionuclides should use radiopharmaceuticals. The recommended dosage can be found in the prescribing information. The drug is manufactured by ROTOP Pharmaсeka GmbH in Germany for Theragnostics Inc, a US-based company. The lot number and expiration date are also specified.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.